Healthcare -
Biotechnology - NASDAQ - US
$ 23.46
-0.509 %
$ 3.38 B
Market Cap
-8.5
P/E
DNLI - COST OF REVENUE
Cost of Revenue DNLI - Denali Therapeutics Inc.
16.7 M
LAST VALUE
72.68%
2 YEAR CAGR
17.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR